JFrog (FROG) 10-Q 8 Nov 24 2024 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2024	Oct. 31, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Registrant Name	JFrog Ltd.
Entity Central Index Key	0001800667
Securities Act File Number	001-39492
Entity Tax Identification Number	98-0680649
Document Quarterly Report	true
Document Transition Report	false
Entity Incorporation, State or Country Code	L3
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Interactive Data Current	Yes
Entity Current Reporting Status	Yes
Entity Address, Address Line One	270 E. Caribbean Drive
Entity Address, City or Town	Sunnyvale
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94089
City Area Code	(408)
Local Phone Number	329-1540
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Title of 12(b) Security	Ordinary Shares, NIS 0.01 par value
Trading Symbol	FROG
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		111,563,211

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 62,246	$ 84,765
Short- term investments	405,540	460,245
Accounts receivable, net	92,892	76,437
Deferred contract acquisition costs	14,929	11,378
Prepaid expenses and other current assets	17,769	12,976
Total current assets	593,376	645,801
Property and equipment, net	6,051	6,663
Deferred contract acquisition costs, noncurrent	22,631	18,032
Operating lease right-of-use assets	16,268	22,427
Intangible assets, net	66,739	25,768
Goodwill	371,377	247,955
Other assets, noncurrent	4,447	5,910
Total assets	1,080,889	972,556
Current liabilities:
Accounts payable	16,282	16,970
Accrued expenses and other current liabilities	43,803	35,815
Operating lease liabilities	8,150	8,272
Deferred revenue	223,985	201,118
Total current liabilities	292,220	262,175
Deferred revenue, noncurrent	20,257	12,987
Operating lease liabilities, noncurrent	7,693	13,954
Other liabilities, noncurrent	4,513	4,317
Total liabilities	324,683	293,433
Commitments and contingencies (Note 11)
Shareholders' equity:
Preferred shares, NIS 0.01 par value per share; 50,000,000 shares authorized; 0 issued and outstanding as of September 30, 2024 and December 31, 2023	0	0
Ordinary shares, NIS 0.01 par value per share, 500,000,000 shares authorized; 111,556,211 and 106,114,892 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	312	297
Additional paid-in capital	1,091,910	968,245
Accumulated other comprehensive income	454	1,013
Accumulated deficit	(336,470)	(290,432)
Total shareholders' equity	756,206	679,123
Total liabilities and shareholders' equity	$ 1,080,889	$ 972,556

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - ₪ / shares	Sep. 30, 2024	Dec. 31, 2023
Preferred stock par value	₪ 0.01	₪ 0.01
Preferred stock authorized	50,000,000	50,000,000
Preferred stock issued	0	0
Preferred stock Outstanding	0	0
Common stock par value	₪ 0.01	₪ 0.01
Common stock Authorized	500,000,000	500,000,000
Common stock issued	111,556,211	106,114,892
Common stock Outstanding	111,556,211	106,114,892

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue:
Total subscription revenue	$ 109,056	$ 88,636	$ 312,410	$ 252,626
Cost of revenue:
Total cost of revenue—subscription	27,291	19,750	69,788	56,620
Gross profit	81,765	68,886	242,622	196,006
Operating expenses:
Research and development	42,996	33,358	115,945	101,788
Sales and marketing	50,956	37,915	140,423	109,753
General and administrative	17,733	15,663	51,937	44,635
Total operating expenses	111,685	86,936	308,305	256,176
Operating loss	(29,920)	(18,050)	(65,683)	(60,170)
Interest and other income, net	5,705	5,733	19,690	14,621
Loss before income taxes	(24,215)	(12,317)	(45,993)	(45,549)
Income tax expense (benefit)	(1,270)	1,430	45	4,474
Net loss	$ (22,945)	$ (13,747)	$ (46,038)	$ (50,023)
Net loss per share, basic	$ (0.21)	$ (0.13)	$ (0.42)	$ (0.49)
Net loss per share, diluted	$ (0.21)	$ (0.13)	$ (0.42)	$ (0.49)
Weighted-average shares used in computing net loss per share, basic	110,771,942	104,134,649	108,920,791	102,646,453
Weighted-average shares used in computing net loss per share, diluted	110,771,942	104,134,649	108,920,791	102,646,453
Subscription—self-managed and SaaS
Revenue:
Total subscription revenue	$ 103,487	$ 84,131	$ 297,297	$ 238,141
Cost of revenue:
Total cost of revenue—subscription	27,156	19,532	69,363	55,966
License—self-managed
Revenue:
Total subscription revenue	5,569	4,505	15,113	14,485
Cost of revenue:
Total cost of revenue—subscription	$ 135	$ 218	$ 425	$ 654

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net Income (Loss)	$ (22,945)	$ (13,747)	$ (46,038)	$ (50,023)
Other comprehensive income (loss), net of tax:
Net change in unrealized gains on available-for-sale marketable securities, net of tax	1,588	449	1,011	156
Net change in unrealized gains (losses) on derivative instruments, net of tax	593	(414)	(1,570)	(826)
Other comprehensive income (loss), net of tax	2,181	35	(559)	(670)
Comprehensive loss	$ (20,764)	$ (13,712)	$ (46,597)	$ (50,693)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Ordinary Shares	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance (in shares) at Dec. 31, 2022		100,907,857
Balance at Dec. 31, 2022	$ 624,773	$ 283	$ 856,438	$ (2,772)	$ (229,176)
Issuance of ordinary shares upon exercise of share options (in shares)		1,290,378
Issuance of ordinary shares upon exercise of share options	5,433	$ 4	5,429
Issuance of ordinary shares upon release of restricted share units (in shares)		2,242,046
Issuance of ordinary shares upon release of restricted share units		$ 6	(6)
Issuance of ordinary shares under the employee share purchase plan (in shares)		369,118
Issuance of ordinary shares under the employee share purchase plan	6,665	$ 1	6,664
Issuance of ordinary shares related to business combination (in shares)		55,466
Share-based compensation expense	66,920		66,920
Other comprehensive income (loss), net of tax	(670)			(670)
Net Income (Loss)	(50,023)				(50,023)
Balance (in shares) at Sep. 30, 2023		104,864,865
Balance at Sep. 30, 2023	653,098	$ 294	935,445	(3,442)	(279,199)
Balance (in shares) at Jun. 30, 2023		103,620,107
Balance at Jun. 30, 2023	635,892	$ 290	904,531	(3,477)	(265,452)
Issuance of ordinary shares upon exercise of share options (in shares)		382,742
Issuance of ordinary shares upon exercise of share options	2,066	$ 2	2,064
Issuance of ordinary shares upon release of restricted share units (in shares)		644,820
Issuance of ordinary shares upon release of restricted share units		$ 2	(2)
Issuance of ordinary shares under the employee share purchase plan (in shares)		161,730
Issuance of ordinary shares under the employee share purchase plan	3,166		3,166
Issuance of ordinary shares related to business combination (in shares)		55,466
Share-based compensation expense	25,686		25,686
Other comprehensive income (loss), net of tax	35			35
Net Income (Loss)	(13,747)				(13,747)
Balance (in shares) at Sep. 30, 2023		104,864,865
Balance at Sep. 30, 2023	653,098	$ 294	935,445	(3,442)	(279,199)
Balance (in shares) at Dec. 31, 2023		106,114,892
Balance at Dec. 31, 2023	$ 679,123	$ 297	968,245	1,013	(290,432)
Issuance of ordinary shares upon exercise of share options (in shares)	1,675,788	1,675,788
Issuance of ordinary shares upon exercise of share options	$ 8,804	$ 5	8,799
Issuance of ordinary shares upon release of restricted share units (in shares)		3,030,370
Issuance of ordinary shares upon release of restricted share units		$ 8	(8)
Issuance of ordinary shares under the employee share purchase plan (in shares)		357,980
Issuance of ordinary shares under the employee share purchase plan	8,744	$ 1	8,743
Issuance of ordinary shares related to business combination (in shares)		377,181
Issuance of ordinary shares related to business combination	13,420	$ 1	13,419
Issuance of replacement awards attributable to pre-combination service in business combination	375		375
Share-based compensation expense	92,337		92,337
Other comprehensive income (loss), net of tax	(559)			(559)
Net Income (Loss)	(46,038)				(46,038)
Balance (in shares) at Sep. 30, 2024		111,556,211
Balance at Sep. 30, 2024	756,206	$ 312	1,091,910	454	(336,470)
Balance (in shares) at Jun. 30, 2024		110,022,835
Balance at Jun. 30, 2024	721,433	$ 308	1,036,377	(1,727)	(313,525)
Issuance of ordinary shares upon exercise of share options (in shares)		127,908
Issuance of ordinary shares upon exercise of share options	1,097	$ 0	1,097
Issuance of ordinary shares upon release of restricted share units (in shares)		848,213
Issuance of ordinary shares upon release of restricted share units		$ 2	(2)
Issuance of ordinary shares under the employee share purchase plan (in shares)		180,074
Issuance of ordinary shares under the employee share purchase plan	4,250	$ 1	4,249
Issuance of ordinary shares related to business combination (in shares)		377,181
Issuance of ordinary shares related to business combination	13,420	$ 1	13,419
Issuance of replacement awards attributable to pre-combination service in business combination	375		375
Share-based compensation expense	36,395		36,395
Other comprehensive income (loss), net of tax	2,181			2,181
Net Income (Loss)	(22,945)				(22,945)
Balance (in shares) at Sep. 30, 2024		111,556,211
Balance at Sep. 30, 2024	$ 756,206	$ 312	$ 1,091,910	$ 454	$ (336,470)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net Income (Loss)	$ (46,038)	$ (50,023)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	14,605	11,512
Share-based compensation expense	92,337	66,920
Non-cash operating lease expense	6,323	6,294
Net amortization of premium or discount on investments	(5,134)	(4,588)
Losses (gains) on foreign exchange	360	(869)
Changes in operating assets and liabilities, net of effects of acquisition:
Accounts receivable	(15,782)	1,337
Prepaid expenses and other assets	(6,923)	530
Deferred contract acquisition costs	(8,150)	(4,769)
Accounts payable	(1,669)	(119)
Accrued expenses and other liabilities	7,958	4,935
Operating lease liabilities	(6,207)	(5,818)
Deferred revenue	30,126	16,220
Net cash provided by operating activities	61,806	41,562
Cash flows from investing activities:
Purchases of short-term investments	(379,546)	(303,310)
Maturities and sales of short-term investments	439,067	266,847
Purchases of property and equipment	(2,509)	(1,364)
Acquisition of business, net of cash acquired	(156,714)	0
Net cash used in investing activities	(99,702)	(37,827)
Cash flows from financing activities:
Proceeds from exercise of share options	8,804	5,433
Proceeds from employee share purchase plan	8,744	6,665
Payments to tax authorities from employee equity transactions, net	(724)	(332)
Net cash provided by financing activities	16,824	11,766
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(700)	(112)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(21,772)	15,389
Cash, cash equivalents, and restricted cash—beginning of period	84,777	45,607
Cash, cash equivalents, and restricted cash—end of period	63,005	60,996
Supplemental disclosures of noncash investing and financing activities:
Fair value of ordinary shares issued as consideration for business acquisition	13,420	0
Fair value of replacement awards in business acquisition	$ 375	$ 0

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Reconciliation of cash, cash equivalents, and restricted cash within the Condensed Consolidated Balance Sheets to the amounts shown in the Condensed Consolidated Statements of Cash Flows above:
Cash and cash equivalents	$ 62,246	$ 60,984
Restricted cash included in prepaid expenses and other current assets	759	12
Total cash, cash equivalents, and restricted cash	$ 63,005	$ 60,996

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (22,945)	$ (13,747)	$ (46,038)	$ (50,023)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	During the three months ended September 30, 2024, the following directors and officers, as defined in Rule 16a-1(f) of the Exchange Act, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K, as follows: On August 12, 2024 , Mr. Frederic Simon , our consultant and member of our board of directors , adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 720,000 ordinary shares. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c) of the Exchange Act. The trading arrangement terminates on the earlier of the date all transactions are completed under the trading arrangement or November 17, 2025 . On August 13, 2024 , Mr. Yoav Landman , our Chief Technology Officer and member of our board of directors , adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 1,735,000 ordinary shares. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c) of the Exchange Act. The trading arrangement terminates on the earlier of the date all transactions are completed under the trading arrangement or November 14, 2025 . On August 16, 2024 , Mr. Eduard Grabscheid , our Chief Financial Officer , adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 31,634 ordinary shares. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c) of the Exchange Act. The trading arrangement terminates on the earlier of the date all transactions are completed under the trading arrangement or August 16, 2025 . On August 16, 2024 , Ms. Jessica Neal , a member of our board of directors , adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 25,000 ordinary shares. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c) of the Exchange Act. The trading arrangement terminates on the earlier of the date all transactions are completed under the trading arrangement or August 16, 2025 . No other officers or directors, as defined in Rule 16a-1(f), adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K, during the three months ended September 30, 2024 .
Mr Yoav Landman [Member]
Trading Arrangements, by Individual
Name	Mr. Yoav Landman
Title	Chief Technology Officer and member of our board of directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 13, 2024
Expiration Date	November 14, 2025
Arrangement Duration	458 days
Aggregate Available	1,735,000
Mr. Frederic Simon [Member]
Trading Arrangements, by Individual
Name	Mr. Frederic Simon
Title	consultant and member of our board of directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 12, 2024
Expiration Date	November 17, 2025
Arrangement Duration	462 days
Aggregate Available	720,000
Mr. Eduard Grabscheid [Member]
Trading Arrangements, by Individual
Name	Mr. Eduard Grabscheid
Title	Chief Financial Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 16, 2024
Expiration Date	August 16, 2025
Arrangement Duration	365 days
Aggregate Available	31,634
Ms. Jessica Neal [Member]
Trading Arrangements, by Individual
Name	Ms. Jessica Neal
Title	member of our board of directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 16, 2024
Expiration Date	August 16, 2025
Arrangement Duration	365 days
Aggregate Available	25,000
Other Officers or Directors [Member]
Trading Arrangements, by Individual
Name	No
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Organization and Description of

Organization and Description of Business	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	1. Organization an d Description of Business JFrog Ltd. (together with its subsidiaries, “JFrog”, or the “Company”) was incorporated under the laws of the State of Israel in 2008. JFrog provides an end-to-end, hybrid, universal Software Supply Chain Platform that enables organizations to continuously and securely create and deliver software updates across any system. This platform is the critical bridge between software development and deployment of that software, paving the way for modern software supply chain management and software release processes. The Company enables organizations to build and release software faster and more securely while empowering developers, security teams and machine learning operations teams to be more efficient. The Company’s solutions are designed to run on-premise, in public or private clouds, or in hybrid environments .

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting, and include the accounts of JFrog Ltd. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of December 31, 2023 was derived from the audited consolidated financial statements as of that date, but does not include all of the disclosures, including certain notes required by GAAP on an annual reporting basis. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes thereto as of and for the year ended December 31, 2023, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 15, 2024. In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair presentation of the Company’s financial position as of September 30, 2024, the Company’s consolidated results of operations and shareholders’ equity for the three and nine months ended September 30, 2024 and 2023, and cash flows for the nine months ended September 30, 2024 and 2023. The results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the full year ending December 31, 2024 or any other future interim or annual period. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods and accompanying notes. Significant items subject to such estimates and assumptions include, but are not limited to, the allocation of transaction price among various performance obligations, the estimated benefit period of deferred contract acquisition costs, the allowance for credit losses, the fair value of acquired intangible assets and goodwill, the useful lives of acquired intangible assets and property and equipment, the incremental borrowing rate for operating leases, and the valuation of deferred tax assets and uncertain tax positions. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates . Significant Accounting Policies The Company’s significant accounting policies are discussed in Note 2, Summary of Significant Accounting Policies, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. There have been no significant changes to these policies during the nine months ended September 30, 2024 . Interest and Other Income, Net Interest and other income, net primarily consists of income earned on cash equivalents and short-term investments and foreign exchange gains and losses. Interest income was $ 5.8 million and $ 6.1 million for the three months ended September 30, 2024 and 2023 , respectively, and $ 20.1 million and $ 15.6 million for the nine months ended September 30, 2024 and 2023 , respectively. Foreign exchange gains (losses) were not material for the periods presented. Geographical Information Revenue by geographical region can be found in Note 3, Revenue Recognition . The following table presents the Company’s long-lived assets by geographic region, which consist of property and equipment, net and operating lease right-of-use assets: September 30, 2024 December 31, 2023 (in thousands) United States $ 6,480 $ 8,566 Israel 12,389 15,888 India 3,179 4,054 Rest of world 271 582 Total long-lived assets $ 22,319 $ 29,090 Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standard Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures , which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. In addition, it provides new segment disclosure requirements for entities with a single reportable segment. The guidance will be effective for the Company for annual periods beginning January 1, 2024 and for interim periods beginning January 1, 2025. Early adoption is permitted. The Company is currently evaluating the impact on its financial statement disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures , which requires disaggregated information about the effective tax rate reconciliation as well as information on income taxes paid. The guidance will be effective for the Company for annual periods beginning January 1, 2025, with e arly adoption permitted. The Company is currently evaluating the impact on its financial statement disclosures.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	3. Revenue Recognition Disaggregation of Revenue The following table presents revenue by category: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Amount Percentage Amount Percentage Amount Percentage Amount Percentage (in thousands, except percentages) Self-managed subscription $ 66,703 61 % $ 58,022 65 % $ 193,858 62 % $ 169,332 67 % Subscription 61,134 56 53,517 60 178,745 57 154,847 61 License 5,569 5 4,505 5 15,113 5 14,485 6 SaaS 42,353 39 30,614 35 118,552 38 83,294 33 Total subscription revenue $ 109,056 100 % $ 88,636 100 % $ 312,410 100 % $ 252,626 100 % The following table summarizes revenue by region based on the shipping address of customers: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Amount Percentage Amount Percentage Amount Percentage Amount Percentage (in thousands, except percentages) United States $ 65,893 60 % $ 55,162 62 % $ 188,884 60 % $ 156,440 62 % Israel 3,267 3 2,216 3 9,032 3 6,490 3 Rest of world 39,896 37 31,258 35 114,494 37 89,696 35 Total subscription revenue $ 109,056 100 % $ 88,636 100 % $ 312,410 100 % $ 252,626 100 % Contract Balances Of the $ 221.3 million and $ 184.4 million of deferred revenue recorded as of June 30, 2024 and 2023, respectively, the Company recognize d $ 88.1 million and $ 69.1 million as revenue during the three months ended September 30, 2024 and 2023 , respectively. Of the $ 214.1 million and $ 175.7 million of deferred revenue recorded as of December 31, 2023 and 2022, respectively, the Company recognized $ 182.7 million and $ 146.4 million as revenue during the nine months ended September 30, 2024 and 2023, respectively. Remaining Performance Obligation The Company’s remaining performance obligations represent contracted revenue that has not yet been recognized, which includes deferred revenue and non-cancelable amounts that will be invoiced and recognized in future periods. As of September 30, 2024, the aggregate a mount of the transaction price allocated to remaining performance obligations was $ 346.1 million, which consists of billed c onsiderations of $ 244.2 million and unbilled consid erations of $ 101.9 million, that the Company expects to recognize as revenue. As of September 30, 2024 , the Company expects to recognize 71 % of its remaining performance obligations as revenue over the next 12 months, and the remainder thereafter. Cost to Obtain a Contract Amortization of deferred contract acquisition costs was $ 3.7 million and $ 2.7 million for the three months ended September 30, 2024 and 2023 , respectively, and $ 10.1 million and $ 7.3 million for the nine months ended September 30, 2024 and 2023, respectively. Significant Customers As of September 30, 2024, one customer accounted for approximately 11 % of the Company’s accounts receivable. No single customer accounted for 10 % or more of accounts receivable as of December 31, 2023. No single customer accounted for more than 10 % of total revenue for the periods presented.

Short-Term Investments

Short-Term Investments	9 Months Ended
	Sep. 30, 2024
Investments, All Other Investments [Abstract]
Short-Term Investments	4. Short-Term Investments Short-term investments consist of bank deposits and marketable securities. As of September 30, 2024 and December 31, 2023 , bank deposits were $ 92.6 million and $ 81.1 million, respectively. Marketable securities consist of the following: September 30, 2024 Amortized Gross Gross Estimated (in thousands) Certificates of deposit $ 251 $ 1 $ — $ 252 Commercial paper 4,395 12 — 4,407 Corporate debt securities 138,452 517 ( 25 ) 138,944 Municipal securities 14,599 45 — 14,644 Government and agency debt 154,315 426 ( 36 ) 154,705 Total marketable securities $ 312,012 $ 1,001 $ ( 61 ) $ 312,952 December 31, 2023 Amortized Gross Gross Estimated (in thousands) Certificates of deposit $ 2,455 $ — $ ( 21 ) $ 2,434 Commercial paper 8,927 — ( 6 ) 8,921 Corporate debt securities 162,515 234 ( 302 ) 162,447 Municipal securities 22,263 9 ( 36 ) 22,236 Government and agency debt 183,093 252 ( 250 ) 183,095 Total marketable securities $ 379,253 $ 495 $ ( 615 ) $ 379,133 The following table summarizes the Company’s marketable securities by contractual maturities: September 30, 2024 (in thousands) Due in 1 year or less $ 223,787 Due in 1 year through 2 years 89,165 Total $ 312,952 The following tables present fair value and gross unrealized losses of the Company’s marketable securities that have been in a continuous loss position, aggregated by length of time: September 30, 2024 Less Than 12 Months 12 Months or Greater Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in thousands) Corporate debt securities $ 14,304 $ ( 18 ) $ 8,540 $ ( 7 ) $ 22,844 $ ( 25 ) Government and agency debt 33,614 ( 35 ) 4,096 ( 1 ) 37,710 ( 36 ) Total $ 47,918 $ ( 53 ) $ 12,636 $ ( 8 ) $ 60,554 $ ( 61 ) December 31, 2023 Less Than 12 Months 12 Months or Greater Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in thousands) Certificates of deposit $ 250 $ — $ 2,175 $ ( 21 ) $ 2,425 $ ( 21 ) Commercial paper 8,921 ( 6 ) — — 8,921 ( 6 ) Corporate debt securities 77,023 ( 177 ) 25,156 ( 125 ) 102,179 ( 302 ) Municipal securities 7,071 ( 6 ) 4,215 ( 30 ) 11,286 ( 36 ) Government and agency debt 99,236 ( 181 ) 8,972 ( 69 ) 108,208 ( 250 ) Total $ 192,501 $ ( 370 ) $ 40,518 $ ( 245 ) $ 233,019 $ ( 615 ) As of September 30, 2024 and December 31, 2023 , the unrealized losses related to marketable securities were determined to be not due to credit related losses. Therefore, the Company did no t recognize an allowance for credit losses. See Note 13, Accumulated Other Comprehensive Income (Loss) , for the realized gains or losses from available-for-sale marketable securities that were reclassified out of accumulated other comprehensive income (loss) (“AOCI”) during the periods presented.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	5. Fair Value Measurements The following tables present information about the Company’s financial instruments that are measured at fair value on a recurring basis: September 30, 2024 Fair Value Level 1 Level 2 (in thousands) Financial Assets: Money market funds $ 22,629 $ 22,629 $ — Corporate debt securities 334 — 334 Cash equivalents 22,963 22,629 334 Certificates of deposit 252 — 252 Commercial paper 4,407 — 4,407 Corporate debt securities 138,944 — 138,944 Municipal securities 14,644 — 14,644 Government and agency debt 154,705 — 154,705 Marketable securities 312,952 — 312,952 Foreign currency contracts designated as hedging instruments included in prepaid expenses and other current assets 312 — 312 Restricted bank deposits included in prepaid expenses and other current assets 12 — 12 Total financial assets $ 336,239 $ 22,629 $ 313,610 Financial Liabilities: Foreign currency contracts designated as hedging instruments included in accrued expenses and other current liabilities $ 745 $ — $ 745 Foreign currency contracts not designated as hedging instruments included in accrued expenses and other current liabilities 147 — 147 Total financial liabilities $ 892 $ — $ 892 December 31, 2023 Fair Value Level 1 Level 2 (in thousands) Financial Assets: Money market funds $ 40,646 $ 40,646 $ — Government and agency debt 5,498 — 5,498 Cash equivalents 46,144 40,646 5,498 Certificates of deposit 2,434 — 2,434 Commercial paper 8,921 — 8,921 Corporate debt securities 162,447 — 162,447 Municipal securities 22,236 — 22,236 Government and agency debt 183,095 — 183,095 Marketable securities 379,133 — 379,133 Foreign currency contracts designated as hedging instruments included in prepaid expenses and other current assets 1,189 — 1,189 Foreign currency contracts not designated as hedging instruments included in prepaid expenses and other current assets 235 — 235 Restricted bank deposits included in prepaid expenses and other current assets 12 — 12 Total financial assets $ 426,713 $ 40,646 $ 386,067 Financial Liabilities: Foreign currency contracts designated as hedging instruments included in accrued expenses and other current liabilities $ 52 $ — $ 52 Foreign currency contracts not designated as hedging instruments included in accrued expenses and other current liabilities 5 — 5 Total financial liabilities $ 57 $ — $ 57 The Company classifies its money market fund within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company classifies its restricted cash, certificates of deposit, commercial paper, corporate debt securities, municipal securities, government and agency debt, and derivative financial instruments within Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. As of September 30, 2024 and December 31, 2023 , the Company did no t have any assets or liabilities valued based on Level 3 valuations.

Derivative Financial Instrument

Derivative Financial Instruments and Hedging	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments and Hedging	6. Derivative Financial Instruments and Hedging The Company enters into foreign currency forward and option contracts with financial institutions to protect against foreign exchange risks, mainly the exposure to changes in the exchange rate of the New Israeli Shekel (“NIS”) against the U.S. dollar that are associated with forecasted future cash flows and certain existing assets and liabilities for up to twelve months. The Company’s primary objective in entering into these contracts is to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates. The Company does not use derivative instruments for trading or speculative purposes. Notional Amount of Foreign Currency Contracts The notional amounts of outstanding foreign currency contracts in U.S. dollar as of the periods presented were as follows: September 30, 2024 December 31, 2023 (in thousands) Derivatives Designated as Hedging Instruments: Foreign currency contracts $ 77,483 $ 46,331 Derivatives Not Designated as Hedging Instruments: Foreign currency contracts 15,663 18,903 Total derivative instruments $ 93,146 $ 65,234 Effect of Foreign Currency Contracts on the Condensed Consolidated Statements of Operations Derivative instruments that hedge the exposure to variability in expected future cash flows are designated as cash flow hedges. The Company records changes in the fair value of these derivatives in AOCI in the Condensed Consolidated Balance Sheets, until the forecasted transaction occurs. Upon occurrence, the Company reclassifies the related gains or losses on the derivative to the same financial statement line item in the Condensed Consolidated Statements of Operations to which the derivative relates. In case the Company discontinues cash flow hedges, it records the related amount in interest and other income, net, on the Condensed Consolidated Statements of Operations. Derivative instruments that hedge the exposure to variability in the fair value of assets or liabilities are currently not designated as hedges for financial reporting purposes. The Company records changes in the fair value of these derivatives in interest and other income, net in the Condensed Consolidated Statements of Operations. The gains (losses) on foreign currency contracts were presented on the Condensed Consolidated Statements of Operations as follows: Derivatives Designated as Hedging Instruments Derivatives Not Designated as Hedging Instruments Three Months Ended September 30, Nine Months Ended September 30, Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 2024 2023 2024 2023 Condensed Statement of Operations Location: (in thousands) Cost of revenue: subscription–self-managed and SaaS $ ( 5 ) $ ( 111 ) $ 5 $ ( 292 ) $ — $ — $ — $ — Research and development ( 51 ) ( 929 ) 43 ( 2,422 ) — — — — Sales and marketing ( 11 ) ( 219 ) 14 ( 559 ) — — — — General and administrative ( 12 ) ( 252 ) 14 ( 648 ) — — — — Interest and other income, net — — — — 247 ( 506 ) ( 315 ) ( 1,325 ) Total gains (losses) recognized in earnings $ ( 79 ) $ ( 1,511 ) $ 76 $ ( 3,921 ) $ 247 $ ( 506 ) $ ( 315 ) $ ( 1,325 ) Effect of Foreign Currency Contracts on Accumulated Other Comprehensive Income Net unrealized gains (losses) of foreign currency contracts designated as hedging instruments, net of tax, are recorded in AOCI. See Note 13, Accumulated Other Comprehensive Income (Loss) , for the effect on other comprehensive income (loss) and the reclassification out of AOCI during the periods presented. All of net deferred losses in AOCI as of September 30, 2024 are expected to be recognized as cost of revenue or operating expenses in the same financial statement line item in the Condensed Consolidated Statements of Operations to which the derivative relates over the next twelve months.

Condensed Consolidated Balanc_3

Condensed Consolidated Balance Sheet Components	9 Months Ended
	Sep. 30, 2024
Balance Sheet Related Disclosures [Abstract]
Condensed Consolidated Balance Sheet Components	7. Condensed Consolidated Balance Sheet Components Property and Equipment, Net Property and equipment, net consisted of the following: September 30, 2024 December 31, 2023 (in thousands) Computer and software $ 11,145 $ 9,030 Furniture and office equipment 3,307 3,135 Leasehold improvements 6,010 6,069 Property and equipment, gross 20,462 18,234 Less: accumulated depreciation and amortization ( 14,411 ) ( 11,571 ) Property and equipment, net $ 6,051 $ 6,663 Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following: September 30, 2024 December 31, 2023 (in thousands) Accrued compensation and benefits $ 29,257 $ 25,166 Accrued expenses 14,546 10,649 Accrued expenses and other current liabilities $ 43,803 $ 35,815

Business Combination

Business Combination	9 Months Ended
	Sep. 30, 2024
Business Combinations [Abstract]
Business Combinations	8. Business Combination On July 9, 2024, the Company acquired all outstanding shares of Qwak AI Ltd. (“Qwak”), a privately-held company based in Israel, which offers an end-to-end platform for deploying, monitoring, and managing machine learning models at scale. The acquisition is expected to enhance the Company’s machine learning model management capabilities, enabling users to streamline the machine learning model lifecycle from development to deployment. The preliminary purchase consideration consisted of the following, subject to net working capital adjustments: Fair Value (in thousands, except share) Cash $ 163,686 JFrog’s ordinary shares ( 377,181 shares) 13,420 Replacement restricted share units (1) 375 Total $ 177,481 _________________________________________ (1) The replacement restricted share units (“RSU”) had a total fair value of $ 8.9 million, of which $ 0.4 million attributable to pre-acquisition service was part of the purchase consideration. The remaining $ 8.5 million is recognized as share-based compensation expense over the vesting period of approximately 4 years. The acquisition also included a holdback arrangement with certain employees of Qwak, totaling $ 17.0 million in cash and 754,360 of the Company’s ordinary shares with a fair value of $ 26.8 million. The consideration will vest in three equal annual installments on the anniversary of the acquisition date. In addition, the Company agreed to pay retention bonuses of approximately $ 2.2 million to Qwak continuing employees over 2 years from the acquisition date. Both the vesting and payout of the holdback and the retention bonuses are subject to continued employment, and as a result, they are recognized as compensation expense over the requisite service periods. The following table summarizes the preliminary fair value of assets acquired and liabilities assumed, subject to subsequent adjustments as the Company may obtain additional information during the measurement period: July 9, 2024 (in thousands) Cash, cash equivalents and restricted cash $ 6,972 Other current assets 826 Intangible assets 52,636 Goodwill 123,422 Other noncurrent assets 118 Current liabilities ( 2,252 ) Deferred tax liabilities, net ( 4,241 ) Total purchase consideration $ 177,481 Goodwill is primarily attributable to expected synergies arising from exp anded product and service offerings. Goodwill is not deductible for income tax purposes. The following table presents components of the identified intangible assets acquired and their estimated useful lives as of the date of acquisition: Fair value Useful Life (in thousands) (in years) Developed technology $ 48,662 5.0 Customer relationships 3,974 1.0 Total intangible assets acquired $ 52,636 The results of operations of Qwak have been included in the Company’s condensed consolidated financial statements since the date of the acquisition. Pro forma results of operations are not presented because the impact of the acquisition is not material to the Company’s condensed consolidated financial statements.

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	9. Goodwill and Intangible Assets, Net Goodwill The following table represents the changes to goodwill: Carrying Amount (in thousands) Balance as of December 31, 2023 $ 247,955 Addition from acquisition 123,422 Balance as of September 30, 2024 $ 371,377 Intangible assets, net Intangible assets consisted of the following as of September 30, 2024: Gross Carrying Accumulated Net Carrying Weighted- (in thousands) (in years) Developed technology $ 99,009 $ ( 37,469 ) $ 61,540 4.0 Customer relationships 9,515 ( 4,397 ) 5,118 1.5 Other intangible assets 1,132 ( 1,051 ) 81 0.2 Total $ 109,656 $ ( 42,917 ) $ 66,739 Intangible assets consisted of the following as of December 31, 2023: Gross Carrying Accumulated Net Carrying Weighted- (in thousands) (in years) Developed technology $ 50,347 $ ( 27,779 ) $ 22,568 2.3 Customer relationships 5,541 ( 2,786 ) 2,755 3.1 Other intangible assets 1,132 ( 687 ) 445 0.9 Total $ 57,020 $ ( 31,252 ) $ 25,768 Amortization expenses for intangible assets were $ 5.9 million and $ 3.0 million for the three months ended September 30, 2024 and 2023 , respectively, and $ 11.7 million and $ 8.9 million for the nine months ended September 30, 2024 and 2023, respectively. The expected future amortization expenses by year related to the intangible assets as of September 30, 2024 are as follows: September 30, 2024 (in thousands) Year Ending December 31, 2024 (Remainder) $ 5,924 2025 20,915 2026 14,974 2027 10,117 2028 9,733 Thereafter 5,076 Total $ 66,739

Leases

Leases	9 Months Ended
	Sep. 30, 2024
Leases [Abstract]
Leases	10. Leases The Company has entered into non-cancelable lease agreements for its offices with lease periods expiring at various dates through March 2028. Components of operating lease expense were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 (in thousands) Operating lease cost $ 2,248 $ 2,350 $ 6,798 $ 6,843 Short-term lease cost 397 148 786 462 Variable lease cost 102 96 320 302 Total operating lease cost $ 2,747 $ 2,594 $ 7,904 $ 7,607 Supplementary cash flow information related to operating leases was as follows: Nine Months Ended September 30, 2024 2023 (in thousands) Cash paid for operating leases $ 6,636 $ 6,369 ROU assets obtained in exchange for new operating lease liabilities $ — $ 2,867 Adjustment to ROU assets upon modification of existing lease $ 164 $ 4,037 As of September 30, 2024 , the weighted-average discount rate is 3.5 % and the weighted-average remaining term is 2.2 years. Maturities of the Company’s operating lease liabilities as of September 30, 2024 were as follows: September 30, 2024 (in thousands) Year Ending December 31, 2024 (Remainder) $ 2,142 2025 8,000 2026 4,635 2027 1,611 2028 155 Total operating lease payments 16,543 Less: imputed interest ( 700 ) Total operating lease liabilities $ 15,843

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies Non-cancelable Purchase Obligations In the normal course of business, the Company enters into non-cancelable purchase commitments with various parties mainly for hosting services, as well as software products and services. As of September 30, 2024, the Company had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows: September 30, 2024 (in thousands) Year Ending December 31, 2024 (Remainder) $ 1,180 2025 17,025 2026 3,251 2027 25 2028 25 Total $ 21,506 Indemnifications and Contingencies The Company enters into indemnification provisions under certain agreements with other parties in the ordinary course of business. In its customer agreements, the Company has agreed to indemnify, defend and hold harmless the indemnified party for third party claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party intellectual property infringement claims. For certain large or strategic customers, the Company has agreed to indemnify, defend and hold harmless the indemnified party for certain additional matters including but not limited to non-compliance with certain representations and warranties made by the Company. Grants from Israeli Innovation Authority The Company has received in the past grants from the Israeli Innovation Authority (“IIA”) and repaid them in full. Still, as any grant recipient, the Company is subject to the provisions of the Israeli Law for the Encouragement of Research, Development and Technological Innovation in the Industry and the regulations and guidelines thereunder (the “Innovation Law”). Pursuant to the Innovation Law, there are restrictions related to transferring intellectual property outside of Israel. Such transfer requires the approval from the IIA. The approval may be subject to a maximum additional payment amount of approximately $ 6.0 million. In the past, the Company received an approval from the IIA to perform a limited development of IIA funded know-how outside of Israel , subject to the terms specified in the IIA approval, including that all of its core R&D activities will remain in Israel. Legal Proceedings In the ordinary course of business, the Co mpany may be subject from time to time to various proceedings, lawsuits, disputes, or claims. The Company investigates these claims as they arise. Although claims are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually or taken together, have a material adverse effect on its business, financial position, results of operations, or cash flows.

Shareholders' Equity and Equity

Shareholders' Equity and Equity Incentive Plans	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Shareholders' Equity and Equity Incentive Plans	12. Shareholders’ Equity and Equity Incentive Plans Equity Incentive Plans Effective January 1, 2024 , the number of ordinary shares authorized for issuance under the 2020 Equity Incentive Plan (the “2020 Plan”) automatically increased by 6,070,667 shares pursuant to the terms of the 2020 Plan. Share Options A summary of share option activity under the Company’s equity incentive plans and related information is as follows: Options Outstanding Outstanding Weighted-Average Exercise Weighted-Average Remaining Aggregate (in thousands, except share, life and per share data) Balance as of December 31, 2023 5,110,390 $ 8.49 4.1 $ 134,171 Exercised ( 1,675,788 ) $ 5.20 $ 58,498 Forfeited ( 35,921 ) $ 16.98 Balance as of September 30, 2024 3,398,681 $ 10.03 4.1 $ 66,267 Exercisable as of September 30, 2024 3,159,001 $ 9.24 4.0 $ 63,897 Restricted Share Units A summary of RSU activity under the Company’s equity incentive plan and related information is as follows, including performance-based RSUs with market conditions: RSUs Unvested RSUs Weighted-Average Unvested as of December 31, 2023 10,006,997 $ 25.91 Granted 5,780,051 $ 34.92 Vested ( 3,030,370 ) $ 26.92 Forfeited ( 1,019,314 ) $ 26.97 Unvested as of September 30, 2024 11,737,364 $ 30.01 The total release date fair value of RSUs was $ 103.3 million during the nine months ended September 30, 2024. Employee Share Purchase Plan Effective January 1, 2024 , the number of ordinary shares authorized for issuance under the 2020 Employee Share Purchase Plan (“ESPP”) automatically increased by 1,061,148 shares pursuant to the terms of ESPP. Shares Reserved for Future Issuance The Company has the following ordinary shares reserved for future issuance: September 30, 2024 Outstanding share options 3,398,681 Outstanding RSUs 11,737,364 Issuable ordinary shares related to business combination 754,360 Shares available for future issuance under the 2020 Plan 15,560,835 Shares available for future issuance under ESPP 4,984,833 Total ordinary shares reserved 36,436,073 Share-Based Compensation The share-based compensation expense by line item in the accompanying Condensed Consolidated Statements of Operations is summarized as follows: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 (in thousands) Cost of revenue: subscription–self-managed and SaaS $ 3,864 $ 2,650 $ 10,203 $ 6,865 Research and development 13,611 8,596 33,453 23,566 Sales and marketing 13,506 8,248 33,759 21,461 General and administrative 5,414 6,192 14,922 15,028 Total share-based compensation expense $ 36,395 $ 25,686 $ 92,337 $ 66,920 As of September 30, 2024 , unrecognized share-based compensation cost related to unvested share-based compensation awards was $ 329.3 million, which is expected to be recognized over a weighted-average period of 2.8 years. Additionally, unrecognized share-based compensation cost related to the Qwak holdback arrangement was $ 24.8 million, which will be recognized over 2.8 years.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	9 Months Ended
	Sep. 30, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Income (Loss)	13. Accumulated Other Comprehensive Income (Loss) The following table summarizes the changes in AOCI by component, net of tax, during the periods presented: Net Unrealized Net Unrealized Total (in thousands) Balance as of December 31, 2023 $ ( 124 ) $ 1,137 $ 1,013 Other comprehensive income (loss) before reclassifications 1,046 ( 1,494 ) ( 448 ) Net realized gains reclassified from AOCI ( 35 ) ( 76 ) ( 111 ) Other comprehensive income (loss) 1,011 ( 1,570 ) ( 559 ) Balance as of September 30, 2024 $ 887 $ ( 433 ) $ 454 Net Unrealized Net Unrealized Total (in thousands) Balance as of December 31, 2022 $ ( 1,694 ) $ ( 1,078 ) $ ( 2,772 ) Other comprehensive loss before reclassifications ( 6 ) ( 4,747 ) ( 4,753 ) Net realized losses reclassified from AOCI 162 3,921 4,083 Other comprehensive income (loss) 156 ( 826 ) ( 670 ) Balance as of September 30, 2023 $ ( 1,538 ) $ ( 1,904 ) $ ( 3,442 )

Income Taxes (Benefit)

Income Taxes (Benefit)	9 Months Ended
	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes (Benefit)	14. Income Taxes (Benefit) The Company’s quarterly tax provision and estimates of its annual effective tax rate are subject to variation due to several factors, including variability in pre-tax income (or loss), the mix of jurisdictions to which such income relates, tax law developments, non-deductible expenses, excess tax benefits from share-based compensation awards, and changes in its valuation allowance. Income tax expense (benefit) was $ ( 1.3 ) million and $ 1.4 million for the three months ended September 30, 2024 and 2023 , respectively, and $ 45 thousand and $ 4.5 million for the nine months ended September 30, 2024 and 2023 , respectively. The income tax expense (benefit) for the periods consisted primarily of income taxes related to the Company’s operations in the United States. In addition, for the three and nine months ended September 30, 2024, income tax expense (benefit) included a discrete tax benefit of $ 4.2 million in Israel attributable to the release of valuation allowance as a result of recognizing deferred tax liabilities associated with the Qwak acquisition. A valuation allowance is provided when it is more likely than not that the deferred tax assets will not be realized. Based on the available objective evidence during nine months ended September 30, 2024, the Company believes it is more likely than not that the tax benefits of the Company’s losses incurred in Israel may not be realized. Gross unrecognized tax benefits were $ 5.4 million as of September 30, 2024 and December 31, 2023. As of September 30, 2024 , the Company does not expect its unrecognized tax benefits to change significantly within the next twelve months.

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Net Loss Per Share	15. Net Loss Per Share The following table sets forth the computation of basic and diluted net loss per share for the periods presented: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 (in thousands, except share and per share data) Numerator: Net loss $ ( 22,945 ) $ ( 13,747 ) $ ( 46,038 ) $ ( 50,023 ) Denominator: Weighted-average shares used in computing net loss per share, basic and diluted 110,771,942 104,134,649 108,920,791 102,646,453 Net loss per share, basic and diluted $ ( 0.21 ) $ ( 0.13 ) $ ( 0.42 ) $ ( 0.49 ) The potential shares of ordinary shares that were excluded from the computation of diluted net loss per share for the periods presented because including them would have been anti-dilutive are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Outstanding share options 3,469,038 5,992,799 3,894,645 6,503,720 Unvested RSUs 11,331,138 10,027,845 10,483,367 8,856,319 Share purchase rights under the ESPP 214,345 59,044 169,366 146,583 Issuable ordinary shares related to business combination 688,763 — 231,264 36,774 Total 15,703,284 16,079,688 14,778,642 15,543,396

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting, and include the accounts of JFrog Ltd. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of December 31, 2023 was derived from the audited consolidated financial statements as of that date, but does not include all of the disclosures, including certain notes required by GAAP on an annual reporting basis. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes thereto as of and for the year ended December 31, 2023, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 15, 2024. In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair presentation of the Company’s financial position as of September 30, 2024, the Company’s consolidated results of operations and shareholders’ equity for the three and nine months ended September 30, 2024 and 2023, and cash flows for the nine months ended September 30, 2024 and 2023. The results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the full year ending December 31, 2024 or any other future interim or annual period.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods and accompanying notes. Significant items subject to such estimates and assumptions include, but are not limited to, the allocation of transaction price among various performance obligations, the estimated benefit period of deferred contract acquisition costs, the allowance for credit losses, the fair value of acquired intangible assets and goodwill, the useful lives of acquired intangible assets and property and equipment, the incremental borrowing rate for operating leases, and the valuation of deferred tax assets and uncertain tax positions. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates .
Significant Accounting Policies	Significant Accounting Policies The Company’s significant accounting policies are discussed in Note 2, Summary of Significant Accounting Policies, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. There have been no significant changes to these policies during the nine months ended September 30, 2024 .
Fair Value Measurements	The Company classifies its money market fund within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company classifies its restricted cash, certificates of deposit, commercial paper, corporate debt securities, municipal securities, government and agency debt, and derivative financial instruments within Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. As of September 30, 2024 and December 31, 2023 , the Company did no t have any assets or liabilities valued based on Level 3 valuations.
Effect of Foreign Currency Contracts on the Condensed Consolidated Statements of Operations	Effect of Foreign Currency Contracts on the Condensed Consolidated Statements of Operations Derivative instruments that hedge the exposure to variability in expected future cash flows are designated as cash flow hedges. The Company records changes in the fair value of these derivatives in AOCI in the Condensed Consolidated Balance Sheets, until the forecasted transaction occurs. Upon occurrence, the Company reclassifies the related gains or losses on the derivative to the same financial statement line item in the Condensed Consolidated Statements of Operations to which the derivative relates. In case the Company discontinues cash flow hedges, it records the related amount in interest and other income, net, on the Condensed Consolidated Statements of Operations. Derivative instruments that hedge the exposure to variability in the fair value of assets or liabilities are currently not designated as hedges for financial reporting purposes. The Company records changes in the fair value of these derivatives in interest and other income, net in the Condensed Consolidated Statements of Operations.
Interest and Other Income, Net	Interest and Other Income, Net Interest and other income, net primarily consists of income earned on cash equivalents and short-term investments and foreign exchange gains and losses. Interest income was $ 5.8 million and $ 6.1 million for the three months ended September 30, 2024 and 2023 , respectively, and $ 20.1 million and $ 15.6 million for the nine months ended September 30, 2024 and 2023 , respectively. Foreign exchange gains (losses) were not material for the periods presented.
Geographical Information	Geographical Information Revenue by geographical region can be found in Note 3, Revenue Recognition . The following table presents the Company’s long-lived assets by geographic region, which consist of property and equipment, net and operating lease right-of-use assets: September 30, 2024 December 31, 2023 (in thousands) United States $ 6,480 $ 8,566 Israel 12,389 15,888 India 3,179 4,054 Rest of world 271 582 Total long-lived assets $ 22,319 $ 29,090
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standard Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures , which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. In addition, it provides new segment disclosure requirements for entities with a single reportable segment. The guidance will be effective for the Company for annual periods beginning January 1, 2024 and for interim periods beginning January 1, 2025. Early adoption is permitted. The Company is currently evaluating the impact on its financial statement disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures , which requires disaggregated information about the effective tax rate reconciliation as well as information on income taxes paid. The guidance will be effective for the Company for annual periods beginning January 1, 2025, with e arly adoption permitted. The Company is currently evaluating the impact on its financial statement disclosures.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Summary of Long Lived Assets by Geographic Region	The following table presents the Company’s long-lived assets by geographic region, which consist of property and equipment, net and operating lease right-of-use assets: September 30, 2024 December 31, 2023 (in thousands) United States $ 6,480 $ 8,566 Israel 12,389 15,888 India 3,179 4,054 Rest of world 271 582 Total long-lived assets $ 22,319 $ 29,090

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Summary of table presents revenue as follows	The following table presents revenue by category: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Amount Percentage Amount Percentage Amount Percentage Amount Percentage (in thousands, except percentages) Self-managed subscription $ 66,703 61 % $ 58,022 65 % $ 193,858 62 % $ 169,332 67 % Subscription 61,134 56 53,517 60 178,745 57 154,847 61 License 5,569 5 4,505 5 15,113 5 14,485 6 SaaS 42,353 39 30,614 35 118,552 38 83,294 33 Total subscription revenue $ 109,056 100 % $ 88,636 100 % $ 312,410 100 % $ 252,626 100 %
Summary of table by region based on the shipping address of customers	The following table summarizes revenue by region based on the shipping address of customers: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Amount Percentage Amount Percentage Amount Percentage Amount Percentage (in thousands, except percentages) United States $ 65,893 60 % $ 55,162 62 % $ 188,884 60 % $ 156,440 62 % Israel 3,267 3 2,216 3 9,032 3 6,490 3 Rest of world 39,896 37 31,258 35 114,494 37 89,696 35 Total subscription revenue $ 109,056 100 % $ 88,636 100 % $ 312,410 100 % $ 252,626 100 %

Short-Term Investments (Tables)

Short-Term Investments (Tables)	9 Months Ended
	Sep. 30, 2024
Investments, All Other Investments [Abstract]
Summary of Marketable Securities	Marketable securities consist of the following: September 30, 2024 Amortized Gross Gross Estimated (in thousands) Certificates of deposit $ 251 $ 1 $ — $ 252 Commercial paper 4,395 12 — 4,407 Corporate debt securities 138,452 517 ( 25 ) 138,944 Municipal securities 14,599 45 — 14,644 Government and agency debt 154,315 426 ( 36 ) 154,705 Total marketable securities $ 312,012 $ 1,001 $ ( 61 ) $ 312,952 December 31, 2023 Amortized Gross Gross Estimated (in thousands) Certificates of deposit $ 2,455 $ — $ ( 21 ) $ 2,434 Commercial paper 8,927 — ( 6 ) 8,921 Corporate debt securities 162,515 234 ( 302 ) 162,447 Municipal securities 22,263 9 ( 36 ) 22,236 Government and agency debt 183,093 252 ( 250 ) 183,095 Total marketable securities $ 379,253 $ 495 $ ( 615 ) $ 379,133
Summary of Company's Marketable Securities by Contractual Maturities	The following table summarizes the Company’s marketable securities by contractual maturities: September 30, 2024 (in thousands) Due in 1 year or less $ 223,787 Due in 1 year through 2 years 89,165 Total $ 312,952
Summary of Presents Fair Value and Gross Unrealized Losses of the Company's Marketable Securities	The following tables present fair value and gross unrealized losses of the Company’s marketable securities that have been in a continuous loss position, aggregated by length of time: September 30, 2024 Less Than 12 Months 12 Months or Greater Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in thousands) Corporate debt securities $ 14,304 $ ( 18 ) $ 8,540 $ ( 7 ) $ 22,844 $ ( 25 ) Government and agency debt 33,614 ( 35 ) 4,096 ( 1 ) 37,710 ( 36 ) Total $ 47,918 $ ( 53 ) $ 12,636 $ ( 8 ) $ 60,554 $ ( 61 ) December 31, 2023 Less Than 12 Months 12 Months or Greater Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in thousands) Certificates of deposit $ 250 $ — $ 2,175 $ ( 21 ) $ 2,425 $ ( 21 ) Commercial paper 8,921 ( 6 ) — — 8,921 ( 6 ) Corporate debt securities 77,023 ( 177 ) 25,156 ( 125 ) 102,179 ( 302 ) Municipal securities 7,071 ( 6 ) 4,215 ( 30 ) 11,286 ( 36 ) Government and agency debt 99,236 ( 181 ) 8,972 ( 69 ) 108,208 ( 250 ) Total $ 192,501 $ ( 370 ) $ 40,518 $ ( 245 ) $ 233,019 $ ( 615 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Summary of Fair Value by Balance Sheet Grouping	The following tables present information about the Company’s financial instruments that are measured at fair value on a recurring basis: September 30, 2024 Fair Value Level 1 Level 2 (in thousands) Financial Assets: Money market funds $ 22,629 $ 22,629 $ — Corporate debt securities 334 — 334 Cash equivalents 22,963 22,629 334 Certificates of deposit 252 — 252 Commercial paper 4,407 — 4,407 Corporate debt securities 138,944 — 138,944 Municipal securities 14,644 — 14,644 Government and agency debt 154,705 — 154,705 Marketable securities 312,952 — 312,952 Foreign currency contracts designated as hedging instruments included in prepaid expenses and other current assets 312 — 312 Restricted bank deposits included in prepaid expenses and other current assets 12 — 12 Total financial assets $ 336,239 $ 22,629 $ 313,610 Financial Liabilities: Foreign currency contracts designated as hedging instruments included in accrued expenses and other current liabilities $ 745 $ — $ 745 Foreign currency contracts not designated as hedging instruments included in accrued expenses and other current liabilities 147 — 147 Total financial liabilities $ 892 $ — $ 892 December 31, 2023 Fair Value Level 1 Level 2 (in thousands) Financial Assets: Money market funds $ 40,646 $ 40,646 $ — Government and agency debt 5,498 — 5,498 Cash equivalents 46,144 40,646 5,498 Certificates of deposit 2,434 — 2,434 Commercial paper 8,921 — 8,921 Corporate debt securities 162,447 — 162,447 Municipal securities 22,236 — 22,236 Government and agency debt 183,095 — 183,095 Marketable securities 379,133 — 379,133 Foreign currency contracts designated as hedging instruments included in prepaid expenses and other current assets 1,189 — 1,189 Foreign currency contracts not designated as hedging instruments included in prepaid expenses and other current assets 235 — 235 Restricted bank deposits included in prepaid expenses and other current assets 12 — 12 Total financial assets $ 426,713 $ 40,646 $ 386,067 Financial Liabilities: Foreign currency contracts designated as hedging instruments included in accrued expenses and other current liabilities $ 52 $ — $ 52 Foreign currency contracts not designated as hedging instruments included in accrued expenses and other current liabilities 5 — 5 Total financial liabilities $ 57 $ — $ 57

Derivative Financial Instrume_2

Derivative Financial Instruments and Hedging (Tables)	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Disclosure of Notional Amount of Derivatives by Hedging Designation	The notional amounts of outstanding foreign currency contracts in U.S. dollar as of the periods presented were as follows: September 30, 2024 December 31, 2023 (in thousands) Derivatives Designated as Hedging Instruments: Foreign currency contracts $ 77,483 $ 46,331 Derivatives Not Designated as Hedging Instruments: Foreign currency contracts 15,663 18,903 Total derivative instruments $ 93,146 $ 65,234
Derivative Instruments, Gain (Loss)	The gains (losses) on foreign currency contracts were presented on the Condensed Consolidated Statements of Operations as follows: Derivatives Designated as Hedging Instruments Derivatives Not Designated as Hedging Instruments Three Months Ended September 30, Nine Months Ended September 30, Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 2024 2023 2024 2023 Condensed Statement of Operations Location: (in thousands) Cost of revenue: subscription–self-managed and SaaS $ ( 5 ) $ ( 111 ) $ 5 $ ( 292 ) $ — $ — $ — $ — Research and development ( 51 ) ( 929 ) 43 ( 2,422 ) — — — — Sales and marketing ( 11 ) ( 219 ) 14 ( 559 ) — — — — General and administrative ( 12 ) ( 252 ) 14 ( 648 ) — — — — Interest and other income, net — — — — 247 ( 506 ) ( 315 ) ( 1,325 ) Total gains (losses) recognized in earnings $ ( 79 ) $ ( 1,511 ) $ 76 $ ( 3,921 ) $ 247 $ ( 506 ) $ ( 315 ) $ ( 1,325 )

Condensed Consolidated Balanc_4

Condensed Consolidated Balance Sheet Components (Tables)	9 Months Ended
	Sep. 30, 2024
Balance Sheet Related Disclosures [Abstract]
Summary of Property and Equipment	Property and equipment, net consisted of the following: September 30, 2024 December 31, 2023 (in thousands) Computer and software $ 11,145 $ 9,030 Furniture and office equipment 3,307 3,135 Leasehold improvements 6,010 6,069 Property and equipment, gross 20,462 18,234 Less: accumulated depreciation and amortization ( 14,411 ) ( 11,571 ) Property and equipment, net $ 6,051 $ 6,663
Summary of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following: September 30, 2024 December 31, 2023 (in thousands) Accrued compensation and benefits $ 29,257 $ 25,166 Accrued expenses 14,546 10,649 Accrued expenses and other current liabilities $ 43,803 $ 35,815

Business Combination (Tables)

Business Combination (Tables)	9 Months Ended
	Sep. 30, 2024
Business Combinations [Abstract]
Summary of Preliminary Purchase Consideration Subject to Net Working Capital Adjustments	The preliminary purchase consideration consisted of the following, subject to net working capital adjustments: Fair Value (in thousands, except share) Cash $ 163,686 JFrog’s ordinary shares ( 377,181 shares) 13,420 Replacement restricted share units (1) 375 Total $ 177,481 _________________________________________ (1) The replacement restricted share units (“RSU”) had a total fair value of $ 8.9 million, of which $ 0.4 million attributable to pre-acquisition service was part of the purchase consideration. The remaining $ 8.5 million is recognized as share-based compensation expense over the vesting period of approximately 4 years.
Summary of Fair Value of Assets Acquired and Liabilities	The following table summarizes the preliminary fair value of assets acquired and liabilities assumed, subject to subsequent adjustments as the Company may obtain additional information during the measurement period: July 9, 2024 (in thousands) Cash, cash equivalents and restricted cash $ 6,972 Other current assets 826 Intangible assets 52,636 Goodwill 123,422 Other noncurrent assets 118 Current liabilities ( 2,252 ) Deferred tax liabilities, net ( 4,241 ) Total purchase consideration $ 177,481
Summary of Components of Identifiable Intangible Assets Acquired and their Estimated Useful Lives	The following table presents components of the identified intangible assets acquired and their estimated useful lives as of the date of acquisition: Fair value Useful Life (in thousands) (in years) Developed technology $ 48,662 5.0 Customer relationships 3,974 1.0 Total intangible assets acquired $ 52,636

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of changes in goodwill	The following table represents the changes to goodwill: Carrying Amount (in thousands) Balance as of December 31, 2023 $ 247,955 Addition from acquisition 123,422 Balance as of September 30, 2024 $ 371,377
Summary of intangible assets	Intangible assets consisted of the following as of September 30, 2024: Gross Carrying Accumulated Net Carrying Weighted- (in thousands) (in years) Developed technology $ 99,009 $ ( 37,469 ) $ 61,540 4.0 Customer relationships 9,515 ( 4,397 ) 5,118 1.5 Other intangible assets 1,132 ( 1,051 ) 81 0.2 Total $ 109,656 $ ( 42,917 ) $ 66,739 Intangible assets consisted of the following as of December 31, 2023: Gross Carrying Accumulated Net Carrying Weighted- (in thousands) (in years) Developed technology $ 50,347 $ ( 27,779 ) $ 22,568 2.3 Customer relationships 5,541 ( 2,786 ) 2,755 3.1 Other intangible assets 1,132 ( 687 ) 445 0.9 Total $ 57,020 $ ( 31,252 ) $ 25,768
Summary of expected future amortization expenses by year related to the intangible assets	The expected future amortization expenses by year related to the intangible assets as of September 30, 2024 are as follows: September 30, 2024 (in thousands) Year Ending December 31, 2024 (Remainder) $ 5,924 2025 20,915 2026 14,974 2027 10,117 2028 9,733 Thereafter 5,076 Total $ 66,739

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2024
Leases [Abstract]
Components of Operating Lease Expense	Components of operating lease expense were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 (in thousands) Operating lease cost $ 2,248 $ 2,350 $ 6,798 $ 6,843 Short-term lease cost 397 148 786 462 Variable lease cost 102 96 320 302 Total operating lease cost $ 2,747 $ 2,594 $ 7,904 $ 7,607
Supplementary Cash Flow Information Related to Operating Leases	Supplementary cash flow information related to operating leases was as follows: Nine Months Ended September 30, 2024 2023 (in thousands) Cash paid for operating leases $ 6,636 $ 6,369 ROU assets obtained in exchange for new operating lease liabilities $ — $ 2,867 Adjustment to ROU assets upon modification of existing lease $ 164 $ 4,037
Summary of Minimum Lease Payments Under Operating Leases	As of September 30, 2024 , the weighted-average discount rate is 3.5 % and the weighted-average remaining term is 2.2 years. Maturities of the Company’s operating lease liabilities as of September 30, 2024 were as follows: September 30, 2024 (in thousands) Year Ending December 31, 2024 (Remainder) $ 2,142 2025 8,000 2026 4,635 2027 1,611 2028 155 Total operating lease payments 16,543 Less: imputed interest ( 700 ) Total operating lease liabilities $ 15,843

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Summary of Outstanding Non-cancelable Purchase Obligations	In the normal course of business, the Company enters into non-cancelable purchase commitments with various parties mainly for hosting services, as well as software products and services. As of September 30, 2024, the Company had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows: September 30, 2024 (in thousands) Year Ending December 31, 2024 (Remainder) $ 1,180 2025 17,025 2026 3,251 2027 25 2028 25 Total $ 21,506

Shareholders' Equity and Equi_2

Shareholders' Equity and Equity Incentive Plans (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Summary of Stock Option Activity	A summary of share option activity under the Company’s equity incentive plans and related information is as follows: Options Outstanding Outstanding Weighted-Average Exercise Weighted-Average Remaining Aggregate (in thousands, except share, life and per share data) Balance as of December 31, 2023 5,110,390 $ 8.49 4.1 $ 134,171 Exercised ( 1,675,788 ) $ 5.20 $ 58,498 Forfeited ( 35,921 ) $ 16.98 Balance as of September 30, 2024 3,398,681 $ 10.03 4.1 $ 66,267 Exercisable as of September 30, 2024 3,159,001 $ 9.24 4.0 $ 63,897
Summary of Restricted Ordinary Shares	A summary of RSU activity under the Company’s equity incentive plan and related information is as follows, including performance-based RSUs with market conditions: RSUs Unvested RSUs Weighted-Average Unvested as of December 31, 2023 10,006,997 $ 25.91 Granted 5,780,051 $ 34.92 Vested ( 3,030,370 ) $ 26.92 Forfeited ( 1,019,314 ) $ 26.97 Unvested as of September 30, 2024 11,737,364 $ 30.01
Summary of Ordinary Shares Reserved for Future Issuance	The Company has the following ordinary shares reserved for future issuance: September 30, 2024 Outstanding share options 3,398,681 Outstanding RSUs 11,737,364 Issuable ordinary shares related to business combination 754,360 Shares available for future issuance under the 2020 Plan 15,560,835 Shares available for future issuance under ESPP 4,984,833 Total ordinary shares reserved 36,436,073
Summary of Stock-Based Compensation Expense	The share-based compensation expense by line item in the accompanying Condensed Consolidated Statements of Operations is summarized as follows: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 (in thousands) Cost of revenue: subscription–self-managed and SaaS $ 3,864 $ 2,650 $ 10,203 $ 6,865 Research and development 13,611 8,596 33,453 23,566 Sales and marketing 13,506 8,248 33,759 21,461 General and administrative 5,414 6,192 14,922 15,028 Total share-based compensation expense $ 36,395 $ 25,686 $ 92,337 $ 66,920

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	9 Months Ended
	Sep. 30, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Summary of changes in AOCI	The following table summarizes the changes in AOCI by component, net of tax, during the periods presented: Net Unrealized Net Unrealized Total (in thousands) Balance as of December 31, 2023 $ ( 124 ) $ 1,137 $ 1,013 Other comprehensive income (loss) before reclassifications 1,046 ( 1,494 ) ( 448 ) Net realized gains reclassified from AOCI ( 35 ) ( 76 ) ( 111 ) Other comprehensive income (loss) 1,011 ( 1,570 ) ( 559 ) Balance as of September 30, 2024 $ 887 $ ( 433 ) $ 454 Net Unrealized Net Unrealized Total (in thousands) Balance as of December 31, 2022 $ ( 1,694 ) $ ( 1,078 ) $ ( 2,772 ) Other comprehensive loss before reclassifications ( 6 ) ( 4,747 ) ( 4,753 ) Net realized losses reclassified from AOCI 162 3,921 4,083 Other comprehensive income (loss) 156 ( 826 ) ( 670 ) Balance as of September 30, 2023 $ ( 1,538 ) $ ( 1,904 ) $ ( 3,442 )

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Summary of computation of basic and diluted net loss per share	The following table sets forth the computation of basic and diluted net loss per share for the periods presented: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 (in thousands, except share and per share data) Numerator: Net loss $ ( 22,945 ) $ ( 13,747 ) $ ( 46,038 ) $ ( 50,023 ) Denominator: Weighted-average shares used in computing net loss per share, basic and diluted 110,771,942 104,134,649 108,920,791 102,646,453 Net loss per share, basic and diluted $ ( 0.21 ) $ ( 0.13 ) $ ( 0.42 ) $ ( 0.49 )
Summary of shares excluded from the computation of diluted net loss per share	The potential shares of ordinary shares that were excluded from the computation of diluted net loss per share for the periods presented because including them would have been anti-dilutive are as follows: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Outstanding share options 3,469,038 5,992,799 3,894,645 6,503,720 Unvested RSUs 11,331,138 10,027,845 10,483,367 8,856,319 Share purchase rights under the ESPP 214,345 59,044 169,366 146,583 Issuable ordinary shares related to business combination 688,763 — 231,264 36,774 Total 15,703,284 16,079,688 14,778,642 15,543,396

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Accounting Policies [Abstract]
Interest income	$ 5.8	$ 6.1	$ 20.1	$ 15.6

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Long Lived Assets by Geographic Region (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Total long lived assets	$ 22,319	$ 29,090
United States
Total long lived assets	6,480	8,566
Israel
Total long lived assets	12,389	15,888
India
Total long lived assets	3,179	4,054
Rest of world
Total long lived assets	$ 271	$ 582

Revenue Recognition - Summary o

Revenue Recognition - Summary of Table Presents Revenue as Follows (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 109,056	$ 88,636	$ 312,410	$ 252,626
Sales revenue [Member] | Product Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage	100%	100%	100%	100%
Subscription
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 61,134	$ 53,517	$ 178,745	$ 154,847
Subscription | Sales revenue [Member] | Product Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage	56%	60%	57%	61%
Selfmanaged Subscription [Member]
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 66,703	$ 58,022	$ 193,858	$ 169,332
Selfmanaged Subscription [Member] | Sales revenue [Member] | Product Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage	61%	65%	62%	67%
License [Member]
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 5,569	$ 4,505	$ 15,113	$ 14,485
License [Member] | Sales revenue [Member] | Product Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage	5%	5%	5%	6%
SaaS [Member]
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 42,353	$ 30,614	$ 118,552	$ 83,294
SaaS [Member] | Sales revenue [Member] | Product Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage	39%	35%	38%	33%

Revenue Recognition - Summary_2

Revenue Recognition - Summary of Revenue by Region Based on The Shipping Address of Customers as Follows (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 109,056	$ 88,636	$ 312,410	$ 252,626
Revenue Benchmark [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage	100%	100%	100%	100%
UNITED STATES
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 65,893	$ 55,162	$ 188,884	$ 156,440
UNITED STATES | Revenue Benchmark [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage	60%	62%	60%	62%
ISRAEL
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 3,267	$ 2,216	$ 9,032	$ 6,490
ISRAEL | Revenue Benchmark [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage	3%	3%	3%	3%
Rest of world [Member]
Disaggregation of Revenue [Line Items]
Total subscription revenue	$ 39,896	$ 31,258	$ 114,494	$ 89,696
Rest of world [Member] | Revenue Benchmark [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage	37%	35%	37%	35%

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Detail) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) Customer	Sep. 30, 2023 USD ($) Customer	Dec. 31, 2023 USD ($) Customer	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Disaggregation of Revenue [Line Items]
Deferred Revenue					$ 214.1	$ 221.3	$ 184.4	$ 175.7
Contract with Customer, Liability, Revenue Recognized	$ 88.1	$ 69.1	$ 182.7	$ 146.4
Revenue, Remaining Performance Obligation	$ 346.1		$ 346.1
Revenue, Remaining Performance Obligation, Percentage	71%		71%
Amortization of deferred contract acquisition costs	$ 3.7	$ 2.7	$ 10.1	$ 7.3
No Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage					10%
Number of customers with concentration risk | Customer					0
No Customer [Member] | Sales revenue [Member] | Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage	10%	10%	10%	10%
Number of customers with concentration risk | Customer			0	0
Customer One [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Concentration risk percentage			11%
Number of customers with concentration risk | Customer			1
Billed Revenues [Member]
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation	$ 244.2		$ 244.2
Unbilled Revenues [Member]
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation	$ 101.9		$ 101.9

Revenue Recognition - Additio_2

Revenue Recognition - Additional Information (Detail 1)	Sep. 30, 2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	12 months

Short-Term Investments - Summar

Short-Term Investments - Summary of Marketable Securities (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Schedule of short term investments [Line Items]
Amortized cost	$ 312,012	$ 379,253
Gross Unrealized Gains	1,001	495
Gross Unrealized Losses	(61)	(615)
Estimated Fair Value	312,952	379,133
Certificates of deposit [Member]
Schedule of short term investments [Line Items]
Amortized cost	251	2,455
Gross Unrealized Gains	1	0
Gross Unrealized Losses	0	(21)
Estimated Fair Value	252	2,434
Commercial paper [Member]
Schedule of short term investments [Line Items]
Amortized cost	4,395	8,927
Gross Unrealized Gains	12	0
Gross Unrealized Losses	0	(6)
Estimated Fair Value	4,407	8,921
Corporate debt securities [Member]
Schedule of short term investments [Line Items]
Amortized cost	138,452	162,515
Gross Unrealized Gains	517	234
Gross Unrealized Losses	(25)	(302)
Estimated Fair Value	138,944	162,447
Municipal securities [Member]
Schedule of short term investments [Line Items]
Amortized cost	14,599	22,263
Gross Unrealized Gains	45	9
Gross Unrealized Losses	0	(36)
Estimated Fair Value	14,644	22,236
Government and agency debt [Member]
Schedule of short term investments [Line Items]
Amortized cost	154,315	183,093
Gross Unrealized Gains	426	252
Gross Unrealized Losses	(36)	(250)
Estimated Fair Value	$ 154,705	$ 183,095

Short-Term Investments - Summ_2

Short-Term Investments - Summary of Company's Marketable Securities by Contractual Maturities (Details) $ in Thousands	Sep. 30, 2024 USD ($)
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]
Due in 1 year or less	$ 223,787
Due in 1 year through 2 years	89,165
Total	$ 312,952

Short-Term Investments - Summ_3

Short-Term Investments - Summary of Presents Fair Value and Gross Unrealized Losses of the Company's Marketable Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]
Fair Value, Less Than 12 Months	$ 47,918	$ 192,501
Gross Unrealized Losses Less Than 12 Months	(53)	(370)
Fair Value, 12 Months or Greater	12,636	40,518
Gross Unrealized Losses 12 Months or Greater	(8)	(245)
Debt Securities, Available-for-Sale, Unrealized Loss Position	60,554	233,019
Gross Unrealized Losses Total	(61)	(615)
Certificates of Deposit [Member]
Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]
Fair Value, Less Than 12 Months		250
Gross Unrealized Losses Less Than 12 Months		0
Fair Value, 12 Months or Greater		2,175
Gross Unrealized Losses 12 Months or Greater		(21)
Debt Securities, Available-for-Sale, Unrealized Loss Position		2,425
Gross Unrealized Losses Total		(21)
Commercial Paper [Member]
Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]
Fair Value, Less Than 12 Months		8,921
Gross Unrealized Losses Less Than 12 Months		(6)
Fair Value, 12 Months or Greater		0
Gross Unrealized Losses 12 Months or Greater		0
Debt Securities, Available-for-Sale, Unrealized Loss Position		8,921
Gross Unrealized Losses Total		(6)
Corporate Debt Securities [Member]
Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]
Fair Value, Less Than 12 Months	14,304	77,023
Gross Unrealized Losses Less Than 12 Months	(18)	(177)
Fair Value, 12 Months or Greater	8,540	25,156
Gross Unrealized Losses 12 Months or Greater	(7)	(125)
Debt Securities, Available-for-Sale, Unrealized Loss Position	22,844	102,179
Gross Unrealized Losses Total	(25)	(302)
Municipal securities [Member]
Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]
Fair Value, Less Than 12 Months		7,071
Gross Unrealized Losses Less Than 12 Months		(6)
Fair Value, 12 Months or Greater		4,215
Gross Unrealized Losses 12 Months or Greater		(30)
Debt Securities, Available-for-Sale, Unrealized Loss Position		11,286
Gross Unrealized Losses Total		(36)
Government and agency debt [Member]
Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]
Fair Value, Less Than 12 Months	33,614	99,236
Gross Unrealized Losses Less Than 12 Months	(35)	(181)
Fair Value, 12 Months or Greater	4,096	8,972
Gross Unrealized Losses 12 Months or Greater	(1)	(69)
Debt Securities, Available-for-Sale, Unrealized Loss Position	37,710	108,208
Gross Unrealized Losses Total	$ (36)	$ (250)

Short-Term Investments - Additi

Short-Term Investments - Additional Information (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Short- term investments	$ 405,540,000	$ 460,245,000
Allowance for credit losses	0	0
Bank deposits [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Short- term investments	$ 92,600,000	$ 81,100,000

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Fair Value by Balance Sheet Grouping (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	$ 312,952	$ 379,133
Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	22,629	40,646
Total financial assets	22,629	40,646
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	334	5,498
Marketable securities	312,952	379,133
Total financial assets	313,610	386,067
Total financial liabilities	892	57
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	22,963	46,144
Marketable securities	312,952	379,133
Total financial assets	336,239	426,713
Total financial liabilities	892	57
Prepaid Expenses and Other Current Assets [Member] | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Restricted bank deposits included in assets	12	12
Prepaid Expenses and Other Current Assets [Member] | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Restricted bank deposits included in assets	12	12
Prepaid Expenses and Other Current Assets [Member] | Designated as Hedging Instrument [Member] | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contract, asset, fair value disclosure	312	1,189
Prepaid Expenses and Other Current Assets [Member] | Designated as Hedging Instrument [Member] | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contract, asset, fair value disclosure	312	1,189
Prepaid Expenses and Other Current Assets [Member] | Not Designated as Hedging Instrument [Member] | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contract, asset, fair value disclosure		235
Prepaid Expenses and Other Current Assets [Member] | Not Designated as Hedging Instrument [Member] | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contract, asset, fair value disclosure		235
Accrued Expenses And Other Current Liabilites [Member] | Designated as Hedging Instrument [Member] | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contracts, liability, fair value disclosure	745	52
Accrued Expenses And Other Current Liabilites [Member] | Designated as Hedging Instrument [Member] | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contracts, liability, fair value disclosure	745	52
Accrued Expenses And Other Current Liabilites [Member] | Not Designated as Hedging Instrument [Member] | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contracts, liability, fair value disclosure	147	5
Accrued Expenses And Other Current Liabilites [Member] | Not Designated as Hedging Instrument [Member] | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency contracts, liability, fair value disclosure	147	5
Money market funds | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	22,629	40,646
Money market funds | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	22,629	40,646
Certificates of deposit | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	252	2,434
Certificates of deposit | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	252	2,434
Commercial paper | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	4,407	8,921
Commercial paper | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	4,407	8,921
Corporate debt securities | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	334
Marketable securities	138,944	162,447
Corporate debt securities | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	334
Marketable securities	138,944	162,447
Municipal securities | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	14,644	22,236
Municipal securities | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	14,644	22,236
Government and agency debt | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents		5,498
Marketable securities	154,705	183,095
Government and agency debt | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents		5,498
Marketable securities	$ 154,705	$ 183,095

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - Level 3 - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total financial assets	$ 0	$ 0
Total financial liabilities	$ 0	$ 0

Derivative Financial Instrume_3

Derivative Financial Instruments and Hedging - Disclosure of Notional Amount of Derivatives by Hedging Designation (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Derivatives, Fair Value [Line Items]
Total derivative instruments	$ 93,146	$ 65,234
Foreign currency contracts [Member] | Derivatives designated as hedging instruments [Member]
Derivatives, Fair Value [Line Items]
Total derivative instruments	77,483	46,331
Foreign currency contracts [Member] | Derivatives not designated as hedging instruments [Member]
Derivatives, Fair Value [Line Items]
Total derivative instruments	$ 15,663	$ 18,903

Derivative Financial Instrume_4

Derivative Financial Instruments and Hedging - Derivative Instruments, Gain (Loss) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Derivatives designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	$ (79)	$ (1,511)	$ 76	$ (3,921)
Derivatives not designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	247	(506)	(315)	(1,325)
Foreign Currency Contracts [Member] | Derivatives not designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	$ 247	$ (506)	$ (315)	$ (1,325)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Nonoperating Income (Expense)	Nonoperating Income (Expense)	Nonoperating Income (Expense)	Nonoperating Income (Expense)
Foreign Currency Contracts [Member] | Subscription–self-managed and SaaS [Member] | Derivatives designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	$ (5)	$ (111)	$ 5	$ (292)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of Revenue	Cost of Revenue	Cost of Revenue	Cost of Revenue
Foreign Currency Contracts [Member] | Research and development [Member] | Derivatives designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	$ (51)	$ (929)	$ 43	$ (2,422)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Research and Development Expense	Research and Development Expense	Research and Development Expense	Research and Development Expense
Foreign Currency Contracts [Member] | Sales and marketing [Member] | Derivatives designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	$ (11)	$ (219)	$ 14	$ (559)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Selling and Marketing Expense	Selling and Marketing Expense	Selling and Marketing Expense	Selling and Marketing Expense
Foreign Currency Contracts [Member] | General and Administrative [Member] | Derivatives designated as hedging instruments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Total gains (losses) recognized in earnings	$ (12)	$ (252)	$ 14	$ (648)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	General and Administrative Expense	General and Administrative Expense	General and Administrative Expense	General and Administrative Expense

Condensed Consolidated Balanc_5

Condensed Consolidated Balance Sheet Components - Summary of Property and Equipment (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 20,462	$ 18,234
Less: accumulated depreciation and amortization	(14,411)	(11,571)
Property and equipment, net	6,051	6,663
Computer and Software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	11,145	9,030
Furniture and Office Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	3,307	3,135
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 6,010	$ 6,069

Condensed Consolidated Balanc_6

Condensed Consolidated Balance Sheet Components - Summary of Accrued Expenses and Other Current Liabilities (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Balance Sheet Related Disclosures [Abstract]
Accrued compensation and benefits	$ 29,257	$ 25,166
Accrued expenses	14,546	10,649
Accrued expenses and other current liabilities	$ 43,803	$ 35,815

Business Combination - Addition

Business Combination - Additional Information (Detail) - Qwak [Member] $ in Millions	Jul. 09, 2024 USD ($) Installment shares
Business Acquisition [Line Items]
Business combination total cash payments under holdback agreements	$ 17
Fair value of share based compensation	$ 26.8
Business combination holdback agreements additional shares issuable | shares	754,360
Holdback vest period | Installment	3
Business Combination Retention Bonus	$ 2.2
Retention bonus payment period	2 years
Restricted Stock Units (RSUs) [Member]
Business Acquisition [Line Items]
Fair value of share based compensation	$ 8.9

Business Combination - Summary

Business Combination - Summary of Preliminary Purchase Consideration Subject to Net Working Capital Adjustments (Detail) - USD ($) $ in Thousands			9 Months Ended
		Jul. 09, 2024	Sep. 30, 2024	Sep. 30, 2023
Business Acquisition [Line Items]
JFrog's ordinary shares (377,181 shares)			$ 13,420	$ 0
Qwak [Member]
Business Acquisition [Line Items]
Cash		$ 163,686
JFrog's ordinary shares (377,181 shares)		13,420
Replacement restricted share units (1)	[1]	375
Total		$ 177,481
[1] The replacement restricted share units (“RSU”) had a total fair value of $ 8.9 million, of which $ 0.4 million attributable to pre-acquisition service was part of the purchase consideration. The remaining $ 8.5 million is recognized as share-based compensation expense over the vesting period of approximately 4 years.

Business Combination - Summar_2

Business Combination - Summary of Preliminary Purchase Consideration Subject to Net Working Capital Adjustments (Parenthetical) (Detail) - Qwak [Member] $ in Millions	Jul. 09, 2024 USD ($) shares
Business Acquisition [Line Items]
JFrog's ordinary shares | shares	377,181
Fair value of share based compensation portion of consideration	$ 26.8
Restricted Stock Units (RSUs) [Member]
Business Acquisition [Line Items]
Fair value of share based compensation portion of consideration	8.9
Share-based purchase price consideration	0.4
Remaining share-based compensation expense consideration	$ 8.5
Share-based compensation vesting period	4 years

Business Combination - Summar_3

Business Combination - Summary of Fair Value of Assets Acquired and Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Jul. 09, 2024	Dec. 31, 2023
Business Acquisition [Line Items]
Goodwill	$ 371,377		$ 247,955
Qwak [Member]
Business Acquisition [Line Items]
Cash, cash equivalents and restricted cash		$ 6,972
Other current assets		826
Intangible assets		52,636
Goodwill		123,422
Other noncurrent assets		118
Current liabilities		(2,252)
Deferred tax liabilities, net		(4,241)
Total purchase consideration		$ 177,481

Business Combination - Summar_4

Business Combination - Summary of Components of Identifiable Intangible Assets Acquired and their Estimated Useful Lives (Details) - Qwak [Member] $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)
Developed Technology [Member]
Business Acquisition [Line Items]
Useful Life	5 years
Customer Relationships [Member]
Business Acquisition [Line Items]
Useful Life	1 year
Portion At Fair Value Disclosure [Member]
Business Acquisition [Line Items]
Fair Value	$ 52,636
Portion At Fair Value Disclosure [Member] | Developed Technology [Member]
Business Acquisition [Line Items]
Fair Value	48,662
Portion At Fair Value Disclosure [Member] | Customer Relationships [Member]
Business Acquisition [Line Items]
Fair Value	$ 3,974

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net - Summary of changes in goodwill (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill, Beginning Balance	$ 247,955
Addition from acquisition	123,422
Goodwill, Ending Balance	$ 371,377

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net - Summary of Intangible Assets (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Intangible Assets [Line items]
Gross Carrying Amount	$ 109,656	$ 57,020
Accumulated Amortization	(42,917)	(31,252)
Net Carrying Amount	66,739	25,768
Developed Technology [Member]
Intangible Assets [Line items]
Gross Carrying Amount	99,009	50,347
Accumulated Amortization	(37,469)	(27,779)
Net Carrying Amount	$ 61,540	$ 22,568
Weighted- Average Remaining Useful Life	4 years	2 years 3 months 18 days
Customer Relationships [Member]
Intangible Assets [Line items]
Gross Carrying Amount	$ 9,515	$ 5,541
Accumulated Amortization	(4,397)	(2,786)
Net Carrying Amount	$ 5,118	$ 2,755
Weighted- Average Remaining Useful Life	1 year 6 months	3 years 1 month 6 days
Other intangible assets [Member]
Intangible Assets [Line items]
Gross Carrying Amount	$ 1,132	$ 1,132
Accumulated Amortization	(1,051)	(687)
Net Carrying Amount	$ 81	$ 445
Weighted- Average Remaining Useful Life	2 months 12 days	10 months 24 days

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Intangible Assets [Line items]
Amortization expenses for intangible assets	$ 5.9	$ 3	$ 11.7	$ 8.9

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net - Summary of Expected Future Amortization Expenses by Year Related to the Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2024 (Remainder)	$ 5,924
2025	20,915
2026	14,974
2027	10,117
2028	9,733
Thereafter	5,076
Net Carrying Amount	$ 66,739	$ 25,768

Leases - Components of Operatin

Leases - Components of Operating Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Lease, Cost [Abstract]
Operating lease cost	$ 2,248	$ 2,350	$ 6,798	$ 6,843
Short-term lease cost	397	148	786	462
Variable lease cost	102	96	320	302
Total operating lease cost	$ 2,747	$ 2,594	$ 7,904	$ 7,607

Leases - Additional Information

Leases - Additional Information (Details)	Sep. 30, 2024
Lessee, Lease, Description [Line Items]
Operating Lease, Weighted Average Remaining Lease Term	2 years 2 months 12 days
Operating Lease, Weighted Average Discount Rate, Percent	3.50%

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information Related to Operating Lease (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Leases [Abstract]
Cash paid for operating leases	$ 6,636	$ 6,369
ROU assets obtained in exchange for new operating lease liabilities	0	2,867
Adjustment to ROU assets upon modification of existing lease	$ 164	$ 4,037

Leases - Schedule of Maturities

Leases - Schedule of Maturities of Operating Lease Liabilities (Details) $ in Thousands	Sep. 30, 2024 USD ($)
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
2024 (Remainder)	$ 2,142
2025	8,000
2026	4,635
2027	1,611
2028	155
Total operating lease payments	16,543
Less: imputed interest	(700)
Total operating lease liabilities	$ 15,843

Commitments and Contingencies -

Commitments and Contingencies - Summary of Outstanding Non-cancelable Purchase Obligations (Detail) $ in Thousands	Sep. 30, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2024 (Remainder)	$ 1,180
2025	17,025
2026	3,251
2027	25
2028	25
Total	$ 21,506

Commitments and Contingencies_2

Commitments and Contingencies - Additional Information (Detail) $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($)
Grants [Member] | Israeli Innovation Authority [Member]
Maximum additional payments as a grant recipient	$ 6

Shareholders' Equity and Equi_3

Shareholders' Equity and Equity Incentive Plans - Additional Information (Detail) - USD ($) $ in Millions		9 Months Ended
	Jan. 01, 2024	Sep. 30, 2024
Unrecognized share-based compensation cost		$ 329.3
Unrecognized share based compensation cost expected to be recognised period		2 years 9 months 18 days
2020 Plan [Member]
Share-based payment arrangement, increase of authorized shares	6,070,667
Employee Share Purchase Plan [Member]
Share-based payment arrangement, increase of authorized shares	1,061,148
Restricted Stock Units (RSUs) [Member]
Fair value of RSU		$ 103.3
Qwak Holdback Arrangement [Member]
Unrecognized share-based compensation cost		$ 24.8
Unrecognized share based compensation cost expected to be recognised period		2 years 9 months 18 days

Shareholders' Equity and Equi_4

Shareholders' Equity and Equity Incentive Plans - Summary of Stock Option Activity (Detail) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares
Share-Based Payment Arrangement [Abstract]
Outstanding Share Options, Beginning balance | shares	5,110,390
Outstanding Share Options, Exercised | shares	(1,675,788)
Outstanding Share Options, Forfeited | shares	(35,921)
Outstanding Share Options, Ending balance | shares	3,398,681	5,110,390
Outstanding Share Options, Exercisable | shares	3,159,001
Weighted Average Exercise Price Per Share, Beginning balance | $ / shares	$ 8.49
Weighted Average Exercise Price Per Share, Exercised | $ / shares	5.2
Weighted Average Exercise Price Per Share, Forfeited | $ / shares	16.98
Weighted Average Exercise Price Per Share, Ending balance | $ / shares	10.03	$ 8.49
Weighted Average Exercise Price Per Share, Exercisable | $ / shares	$ 9.24
Weighted Average Remaining Contractual Life	4 years 1 month 6 days	4 years 1 month 6 days
Weighted Average Remaining Contractual Life, Exercisable	4 years
Aggregate Intrinsic Value, Beginning balance | $	$ 134,171
Aggregate Intrinsic Value, Exercised | $	58,498
Aggregate Intrinsic Value, Ending balance | $	66,267	$ 134,171
Aggregate Intrinsic Value, Exercisable | $	$ 63,897

Shareholders' Equity and Equi_5

Shareholders' Equity and Equity Incentive Plans - Summary of Restricted Ordinary Shares (Detail) - Restricted Stock Units (RSUs) [Member]	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unvested RSUs, Beginning balance | shares	10,006,997
Unvested RSUs, Granted | shares	5,780,051
Unvested RSUs, Vested | shares	(3,030,370)
Unvested RSUs, Forfeited | shares	(1,019,314)
Unvested RSUs, Ending balance | shares	11,737,364
Weighted Average Grant Date Fair Value Per Share, Beginning balance | $ / shares	$ 25.91
Weighted Average Grant Date Fair Value Per Share, Granted | $ / shares	34.92
Weighted Average Grant Date Fair Value Per Share, Vested | $ / shares	26.92
Weighted Average Grant Date Fair Value Per Share, Forfeited | $ / shares	26.97
Weighted Average Grant Date Fair Value Per Share, Ending balance | $ / shares	$ 30.01

Shareholders' Equity and Equi_6

Shareholders' Equity and Equity Incentive Plans - Summary of Ordinary Shares Reserved for Future Issuance (Detail)	Sep. 30, 2024 shares
Class of Stock [Line Items]
Common Stock Reserved for Future Issuance	36,436,073
2020 Plan [Member]
Class of Stock [Line Items]
Common Stock Reserved for Future Issuance	15,560,835
Employee Stock Purchase Plan [Member]
Class of Stock [Line Items]
Common Stock Reserved for Future Issuance	4,984,833
Employee Stock Option
Class of Stock [Line Items]
Common Stock Reserved for Future Issuance	3,398,681
Restricted Stock Units (RSUs) [Member]
Class of Stock [Line Items]
Common Stock Reserved for Future Issuance	11,737,364
Issuable ordinary shares related to business combination [Member]
Class of Stock [Line Items]
Common Stock Reserved for Future Issuance	754,360

Shareholders' Equity and Equi_7

Shareholders' Equity and Equity Incentive Plans - Summary of Stock-based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 36,395	$ 25,686	$ 92,337	$ 66,920
Cost of Revenue [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	3,864	2,650	10,203	6,865
Research and Development [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	13,611	8,596	33,453	23,566
Sales and Marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	13,506	8,248	33,759	21,461
General and Administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 5,414	$ 6,192	$ 14,922	$ 15,028

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) - Summary of Changes In AOCI (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Changes in Accumulated Other Comprehensive Income [Line items]
Beginning Balance			$ 1,013	$ (2,772)
Other comprehensive income (loss) before reclassifications			(448)	(4,753)
Net realized gains reclassified from AOCI			(111)	4,083
Other comprehensive income (loss), net of tax	$ 2,181	$ 35	(559)	(670)
Ending Balance	454	(3,442)	454	(3,442)
Net Unrealized Gains (Losses) on Available-for-Sale Marketable Securities [Member]
Changes in Accumulated Other Comprehensive Income [Line items]
Beginning Balance			(124)	(1,694)
Other comprehensive income (loss) before reclassifications			1,046	(6)
Net realized gains reclassified from AOCI			(35)	162
Other comprehensive income (loss), net of tax			1,011	156
Ending Balance	887	(1,538)	887	(1,538)
Net Unrealized Gains (Losses) on Derivatives Designated as Hedging Instruments [Member]
Changes in Accumulated Other Comprehensive Income [Line items]
Beginning Balance			1,137	(1,078)
Other comprehensive income (loss) before reclassifications			(1,494)	(4,747)
Net realized gains reclassified from AOCI			(76)	3,921
Other comprehensive income (loss), net of tax			(1,570)	(826)
Ending Balance	$ (433)	$ (1,904)	$ (433)	$ (1,904)

Income Taxes (Benefit) - Additi

Income Taxes (Benefit) - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Restructuring Cost and Reserve [Line Items]
Income tax expense	$ (1,270)	$ 1,430	$ 45	$ 4,474
Unrecognized tax benefits	5,400		5,400		$ 5,400
Qwak [Member]
Restructuring Cost and Reserve [Line Items]
Discrete tax benefit	$ (4,200)		$ (4,200)

Net Loss Per Share - Summary of

Net Loss Per Share - Summary of Computation of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Numerator:
Net loss	$ (22,945)	$ (13,747)	$ (46,038)	$ (50,023)
Denominator:
Weighted-average shares used in computing net loss per share, basic	110,771,942	104,134,649	108,920,791	102,646,453
Weighted-average shares used in computing net loss per share, diluted	110,771,942	104,134,649	108,920,791	102,646,453
Net loss per share, basic	$ (0.21)	$ (0.13)	$ (0.42)	$ (0.49)
Net loss per share, diluted	$ (0.21)	$ (0.13)	$ (0.42)	$ (0.49)

Net Loss Per Share - Summary _2

Net Loss Per Share - Summary of Shares Excluded From the Computation of Diluted Net Loss Per Share (Detail) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from computation of diluted net loss per share	15,703,284	16,079,688	14,778,642	15,543,396
Outstanding share options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from computation of diluted net loss per share	3,469,038	5,992,799	3,894,645	6,503,720
Unvested RSUs [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from computation of diluted net loss per share	11,331,138	10,027,845	10,483,367	8,856,319
Share purchase rights under the ESPP [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from computation of diluted net loss per share	214,345	59,044	169,366	146,583
Issuable ordinary shares related to business combination
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from computation of diluted net loss per share	688,763	0	231,264	36,774